Stay updated with breaking news from David Elsley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart...
Risk Awards 2017: Simple vision has taken rates business a long way Risk Awards 2017: Simple vision has taken rates business a long way
Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart...
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) announced it has successfully enrolled over 50% of the targeted number of patients for its Phase II open-label...
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) CEO David Elsley joined Steve Darling from Proactive with news the company has unveiled highly promising study...